References
- Engelhard D., Marks M. I., Good R. A. Infections in bone marrow transplant recipients. J. Pediat. 1986; 108: 335–346
- Meyers J. E., Flournoy N., Thomas E. D. Risk factors for cytomegalovirus infection after human marrow transplantation. J. Infect. Dis. 1986; 153: 478–482
- Apperley J. F., Goldman J. M. Cytomegalovirus: biology, clinical features and methods for diagnosis. Bone Marrow Transplant 1988; 3: 253–264
- Engelhard D., Or R., Strauss N., Morag A., Aker M., Naparstek E., Breuer R., Ravid Z., Sarov I., Lijovetzky G., Hardan I., Slavin S. Cytomegalovirus infection and disease after T-cell depleted allogeneic bone marrow transplantation for malignant hematological diseases. Transplantation Proceedings 1989; 21: 310–313
- Matthews T., Boehme R. Antiviral activity and mechanism of action of ganciclovir. Rev. Infect. Dis. 1988; 10: S490–S494
- Winston D. J., Ho W. G., Martoni K., et al. Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients. Rev. Infect. Dis. 1988; 10: S547–S553
- Emanuel D. Treatment of cytomegalovirus disease. Sem. Hematol 1990; 27: 22–27
- Mills J., Jacobson M. A., O'Donnell J. J., et al. Treatment of cytomegalovirus retinitis in patients with AIDS. Rev. Infect. Dis. 1988; 10: S522–S531
- Emanuel D., Cunningham I., Jules-Elysee K., et al. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann. Intern. Med. 1988; 109: 777–782
- Reed E. C., Bowden R. A., Dandliker P. S., et al. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann. Intern. Med. 1988; 109: 783–788
- Reed E. C., Wolford J. L., Kopecky K. J., et al. Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients. Ann. Inter. Med. 1990; 112: 505–510
- Waldmann H., Polliack A., Hale G., et al. Elimination of graft-versus-host disease by in- vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1). Lancet 1984; 2: 483–465
- Zaia J. A. The biology of human cytomegalovirus infection after bone marrow transplantation. Internal. J. Cell. Cloning. 1986; 4((Suppl 1))135–154